LEADS BIOLABS-B(09887): Wu Fenglan appointed as a non-executive director.
Weili Zhibo-B (09887) announced that Dr. Wu Fenglan has been appointed as a non-executive director of the company, effective from May 15, 2026, until the expiration of the first term of the board of directors. According to the company's articles of association, Dr. Wu is eligible for re-election at the shareholders' meeting after the expiration of her term.
LEADS BIOLABS-B(09887) announces that Dr. Wu Fenglan has been appointed as a non-executive director of the company, effective from May 15, 2026, until the expiration of the first term of the board of directors. According to the company's articles of association, Dr. Wu is eligible for re-election at the shareholder meeting after his term expires.
Related Articles
In the first quarter, the operating profit of HWORLD-S (01179) was 1.5 billion yuan, an increase of 37.5% year-on-year.
On May 15, AV Concept Holdings (00595) spent HKD 4.3611 million to repurchase 3.928 million shares.
FOSUN INTL (00656) repurchased 2 million shares for HKD 8.18 million on May 15th.
In the first quarter, the operating profit of HWORLD-S (01179) was 1.5 billion yuan, an increase of 37.5% year-on-year.
On May 15, AV Concept Holdings (00595) spent HKD 4.3611 million to repurchase 3.928 million shares.
FOSUN INTL (00656) repurchased 2 million shares for HKD 8.18 million on May 15th.
